Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Primary Target

skeletal muscle contraction

3

Histamine H1 receptor

315

Dopamine D2 receptor

297

DNA

278

Bacterial penicillin-binding protein

233

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

Possibly Marketed Outside US

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Low back pain

2

Neck-shoulder-arm syndrome

2

Scapulohumeral periarthritis

2

Spastic paralysis

2

Respiratory and circulatory insufficiency

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Palliative

2

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Eisai|Sannova

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

3

ChEMBL

3

EPA CompTox

3

EVMPD

3

FDA UNII

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

MUSCULO-SKELETAL SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

MUSCLE RELAXANTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other centrally acting agents

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

2

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 3 of 3 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DIMORPHOLAMINE

8YL4JT0L91

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

skeletal muscle contraction

Conditions:

Respiratory and circulatory insufficiency

Dimorpholamine is reported as an ingredient of Theraptique in Japan. Dimorpholamine stimulates the respiratory and circulatory centers to increase the respiratory volume and blood pressure. It is indicated for the respiratory and circulatory insuffic...

iency due to shock, hypnotic intoxication. drowning, pneumonia, and high fever.

EPERISONE

2M2P0551D3

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

skeletal muscle contraction

Conditions:

Scapulohumeral periarthritis

Spastic paralysis

Neck-shoulder-arm syndrome

Eperisone is an antispasmodic drug approved in Japan for the treatment of of diseases characterized by muscle stiffness and pain. It is believed that eperisone exerts its effect through inhibition of sodium channels. The drug is still being marketed ...

in Asia under the name Myonal (Square Pharmaceuticals).

EPERISONE HYDROCHLORIDE

U38O8U7P6X

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

skeletal muscle contraction

Conditions:

Scapulohumeral periarthritis

Spastic paralysis

Neck-shoulder-arm syndrome

Eperisone is an antispasmodic drug approved in Japan for the treatment of of diseases characterized by muscle stiffness and pain. It is believed that eperisone exerts its effect through inhibition of sodium channels. The drug is still being marketed ...

in Asia under the name Myonal (Square Pharmaceuticals).

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1